Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

项目2VIDA！

• 批准号: 10551898
• 负责人: Argentina Elisa Noelle Servin
• 金额: $ 58.45万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-23 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10551898
• 关键词: 18 year old; Acceleration; Address; Adult; Affect; African American; Area; Awareness; Behavior; Belief; Biological Factors; COVID-19; COVID-19 impact; COVID-19 mortality; COVID-19 vaccination; COVID-19 vaccine; California; Centers for Disease Control and Prevention (U.S.); Cessation of life; Characteristics; Client satisfaction; Communities; Community Health; Community Outreach; Community Participation; Country; County; Data; Education; Equity; Essential worker; Fright; Genetic; Geographic Locations; Government; Handwashing; Health; Health Promotion; Healthcare; Home; Human Rights; Immunization; Immunization Programs; Individual; Infection; Intervention; Knowledge; Latino; Latinx; Latinx population; Masks; Medical; Methods; Modeling; Nature; Neighborhood Health Center; Not Hispanic or Latino; Occupations; Outcome; Participant; Perception; Persons; Phase; Policies; Population; Prevention; Preventive; Randomized, Controlled Trials; Recommendation; Recording of previous events; Reporting; Research; Risk; Series; Services; Site; Social Distance; Strategic Planning; Trust; United States; United States National Institutes of Health; Vaccination; Vaccines; Virus; Vulnerable Populations; World Health Organization; acceptability and feasibility; adverse outcome; community based participatory research; comparison control; contextual factors; demographics; ethnic minority; evidence base; experience; follow-up; health care availability; health care service utilization; health disparity; health disparity populations; hospitalization rates; implementation intervention; improved; indicated prevention; infection rate; interest; intervention delivery; intervention effect; intervention refinement; marginalization; pandemic disease; pandemic impact; participant retention; people of color; prevent; racial minority; racism; recruit; satisfaction; scale up; social; social factors; sociodemographics; standard of care; uptake; vaccination protocol; vaccine acceptance; vaccine access; vaccine hesitancy; working group

PROJECT SUMMARY As of January 2021, the World Health Organization (WHO) reports that 89 million cases of COVID-19 (SARS- CoV-2) have been confirmed and have resulted in more than 1.9 million deaths globally. Currently, the United States (U.S.) is the country with the largest number of infections and deaths due to COVID-19, with a total of 22 million infections and 373,167 deaths. Furthermore, early findings that have examined COVID-19 demographics show that racial and ethnic minorities in the U.S. are bearing a disproportionate number of COVID-19 cases and deaths irrespective of geographic region. While there's no evidence that people of color (POC) have genetic or biological factors that make them more likely to be affected by COVID-19, they are more likely to have underlying health conditions, live in multi-generational homes, live in densely populated areas, have limited access to healthcare, and have jobs that are considered essential and involve interaction with the public. All of these factors contribute to higher rates of infection and adverse outcomes due to COVID-19. Although COVID-19 preventive behaviors such as hand washing, mask wearing, and social distancing have been shown to be effective in curbing the spread of the virus, acceptance and uptake of COVID-19 vaccines will be instrumental to ending the pandemic. However, public confidence in vaccination is fragile, especially among racial and ethnic minorities. To this end, we have formed an intervention working group comprised of representatives from community and academic organizations to address challenges in COVID-19 vaccination uptake among Latinx and African American (AA) communities in Southern California by using a community-based participatory research (CBPR) approach. Project 2VIDA! (SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California), is a multilevel intervention to address individual, social, and contextual factors related to access to, and acceptance of, the COVID-19 vaccine among Latinx and AA adults (>18 years old) across six highly affected communities in Southeast San Diego. 2VIDA! seeks to implement and assess a COVID-19 vaccination protocol to increase interest and uptake of COVID-19 vaccine, provide COVID-19 vaccines in the community, and establish a model for the rapid vaccination of Latino and AA adults that could be generalizable to other highly affected communities. 2VIDA! builds on our previous CBPR efforts and centers on conducting COVID-19 community outreach and health promotion, Individual awareness and education, and linkages to medical and supportive services and offering the COVID-19 vaccine to Latinx and AA adults (>18 years old) in community health centers (CHC) and mini-vaccination stations in communities highly impacted by the pandemic in San Diego County.

项目概要 截至 2021 年 1 月，世界卫生组织 (WHO) 报告称，已有 8900 万例 COVID-19（SARS- CoV-2）已得到证实，并已导致全球超过 190 万人死亡。目前，联合国 各州（美国）是因 COVID-19 感染和死亡人数最多的国家，总共有 2200 万人感染，373,167 人死亡。此外，检查 COVID-19 的早期发现 人口统计数据显示，美国的少数族裔人口数量不成比例。 COVID-19 病例和死亡人数，无论地理区域如何。虽然没有证据表明有色人种 (POC) 具有使他们更容易受到 COVID-19 影响的遗传或生物因素，他们是 更有可能有潜在的健康问题、居住在多代同堂的家庭、居住在人口稠密的地方 地区，获得医疗保健的机会有限，并且从事被认为必不可少且涉及互动的工作 与公众。所有这些因素都会导致 COVID-19 的感染率和不良后果更高。尽管洗手、戴口罩和保持社交距离等 COVID-19 预防行为 已被证明可以有效遏制病毒的传播、COVID-19 的接受和吸收 疫苗将有助于结束这一流行病。然而，公众对疫苗接种的信心却很脆弱， 尤其是在少数种族和族裔中。为此，我们成立了干预工作组 由社区和学术组织的代表组成，共同应对 COVID-19 的挑战 南加州拉丁裔和非裔美国人 (AA) 社区的疫苗接种情况 基于社区的参与性研究（CBPR）方法。项目2VIDA！ （SARS-CoV-2 疫苗干预 南加州成人分娩）是一项多层次干预措施，旨在解决个人、社会和 与拉丁裔和 AA 成年人获取和接受 COVID-19 疫苗相关的背景因素 （> 18 岁）位于圣地亚哥东南部六个受影响严重的社区。 2维达！力求实施 评估 COVID-19 疫苗接种方案，以提高人们对 COVID-19 疫苗的兴趣和使用率，提供 在社区中接种 COVID-19 疫苗，并建立拉丁裔和 AA 成年人快速疫苗接种模型 这可以推广到其他受影响严重的社区。 2维达！以我们之前的 CBPR 努力为基础 并以开展 COVID-19 社区外展和健康促进、个人意识和 教育、与医疗和支持服务的联系以及向拉丁裔和拉丁裔提供 COVID-19 疫苗 社区卫生中心 (CHC) 和社区小型疫苗接种站的 AA 成年人（>18 岁） 圣地亚哥县受疫情影响严重。